EUVIMEDOpdag EUVIMED
CrossrefInfokort

CD39 is Expressed by a Wide Range of Cutaneous T-Cell Lymphomas

Gilles Battesti, Nicolas Thonnart, Alizée Bozonnat, Caroline Ram-Wolff, Adèle de Masson, Armand Bensussan, Martine Bagot, Anne Marie-Cardine, Maxime Battistella

Skin Health and Disease · 2024-04-01 · 4 (2)

DOI: 10.1002/ski2.334 ↗
AbstractBibliografiske oplysninger

Abstract

CD39, an ectoenzyme in the immunosuppressive CD39/CD73/adenosine pathway, known to promote solid tumour outgrowth and spreading, was investigated in both skin and blood compartments of cutaneous T cell lymphomas. CD39 was overexpressed by peripheral blood T-cells in Sezary syndrome and mycosis fungoides, and in skin-infiltrating lymphocytes of Sezary syndrome, mycosis fungoides, subcutaneous panniculitis-like T-cell lymphoma and primary cutaneous CD30-positive lymphoproliferation. Our study emphasizes the interest in using CD39/CD73/adenosine pathway blocking agents for cutaneous T cell lymphomas treatment.

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.

Se priser →